ADIM
DCT

Alpha DNA Investment Management’s Duck Creek Technologies, Inc. Common Stock DCT Stock Holding History

Alpha DNA Investment Management’s Portfolio DCT Stock Details DCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40
Closed -$1K – 807
2020
Q4 		$1K Buy
+40
New +$1.69K ﹤0.01% 570

Other funds holding DCT

A
Accenture Dublin, Ireland $254M AUM 59.98% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha DNA Investment Management's DCT Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Duck Creek Technologies, Inc. Common Stock (DCT) in Q1 2021, closing a stake of 40 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in DCT in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 171 funds tracked by Wall St. Rank hold DCT as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Duck Creek Technologies, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 40 Duck Creek Technologies, Inc. Common Stock shares in Q1 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Duck Creek Technologies, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Duck Creek Technologies, Inc. Common Stock position peaked at $1K in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Duck Creek Technologies, Inc. Common Stock as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.